Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
New Insights Into Uveitis Revealed By Fluorescence Lifetime Imaging Ophthalmoscopy
Author Affiliations & Notes
  • Alexandra Vitale
    University of Utah Health John A Moran Eye Center, Salt Lake City, Utah, United States
  • Footnotes
    Commercial Relationships   Alexandra Vitale None
  • Footnotes
    Support  Not applicable, the Heidelberg FLIO device was provided at no cost
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 4258. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Alexandra Vitale; New Insights Into Uveitis Revealed By Fluorescence Lifetime Imaging Ophthalmoscopy. Invest. Ophthalmol. Vis. Sci. 2024;65(7):4258.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Presentation Description : Uveitis can affect individuals of all ages but can present ambiguously both clinically and phenotypically. Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO) is a new and non-invasive imaging method that may be useful in diagnosing, discriminating, and monitoring various Uveitic diseases. FLIO has proven useful in categorizing uveitic diseases in over 100 patients based on phenotype alone. Some diseases include birdshot chorioretinopathy (BCR), punctate inner choroidopathy (PIC), multifocal choroiditis with panuveitis, autoimmune retinopathy, and many others. Utilizing FLIO in patients with uveitis may improve disease detection, help monitor its progression, and aid in further understanding of disease pathophysiology.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×